U.S. Entertainment Stock News

With no single headline event setting the tone, Amphastar Pharmaceuticals (AMPH) draws attention through its recent trading pattern, including a 3.4% move over the past week and a last close of $27.62. See our latest analysis for Amphastar Pharmaceuticals. That recent 1-day share price return of 3.37% and 7-day share price return of 2.30% comes on top of a 90-day share price return of 6.31%. The 1-year total shareholder return of a 21.65% decline contrasts with a 41.50% total shareholder...

In December 2025, Doximity agreed to a US$31 million, insurance-funded settlement to resolve a federal securities lawsuit, with all claims against the company and its executives dismissed without any admission of wrongdoing, pending court and shareholder approvals. At the same time, Doximity’s strong quarterly revenue growth and new AI tools for clinicians highlight how its core business momentum continues alongside legal resolution efforts. With the securities lawsuit settlement set to be...

SharkNinja, Inc. has added Jason Wortendyke, Managing Director and Head of Midwest Investment Banking at Cantor Fitzgerald, to its Board of Directors and Compensation Committee, while also confirming its participation in a webcast fireside chat at the ICR Conference in Orlando on January 12, 2026. Bringing more than 25 years of global investment banking experience across industrial and consumer sectors, Wortendyke’s appointment underscores SharkNinja’s focus on complex transactions, capital...

In late December 2025, Carl Icahn bought more than 30 million additional units of Icahn Enterprises LP, lifting his and affiliated holdings to about 549 million units and further concentrating ownership in the partnership. This large insider purchase deepens Icahn’s control, meaning shifts in his positioning and disclosures around the portfolio, debt, and distributions may carry extra weight for other unitholders. We’ll now examine how Icahn’s larger ownership stake and resulting ownership...

Recent attention on Rockwell Automation (ROK) centers on its push into AI, digital twins, and cloud-based industrial software, along with guidance that reflects recurring demand from AI-enabled factory and warehouse automation projects. See our latest analysis for Rockwell Automation. The latest AI and digital software updates come as Rockwell Automation’s share price sits at US$413.36, with a 90 day share price return of 18.74% and a 1 year total shareholder return of 49.34%, which reflects...

OncoNano Medicine recently announced a research collaboration with Gilead Sciences to test its ON-BOARD encapsulation technology with a Gilead drug candidate, with OncoNano receiving an upfront payment plus potential preclinical, development, regulatory and commercial milestones, and royalties tied to future net sales. The agreement also gives Gilead an option to nominate an additional target that could take total potential upfront and milestone payments to as much as US$300.00 billion,...

In the past week, life sciences company Azenta saw its investment case revisited after Evercore ISI Group upgraded the stock’s rating to “Outperform,” signaling increased analyst confidence in its business outlook. This upgrade stands out because it follows a period of mixed financial results, suggesting analysts see improving fundamentals despite recent operational challenges. We’ll now explore how Evercore’s more positive stance may influence Azenta’s existing investment narrative around...

Recent leadership moves are in the spotlight for Power Integrations (POWI), with investors reacting to the appointments of Nancy Erba as CFO and Chris Jacobs as Senior Vice President for Marketing and Product Strategy. See our latest analysis for Power Integrations. The leadership appointments come as the stock shows short term momentum, with a 7 day share price return of 10.25% and a 30 day share price return of 8.68%, in contrast to a 1 year total shareholder return decline of 35.39%. This...

Recent attention on Harmony Biosciences Holdings (HRMY) centers on progress in clinical trials for new uses of its lead drug WAKIX and other pipeline candidates such as Pitolisant and ZYN-002 targeting rare neurological disorders. See our latest analysis for Harmony Biosciences Holdings. At a recent share price of US$36.75, Harmony’s 90 day share price return of 38.37% contrasts with a slightly negative year to date share price return and a modest 4.46% 1 year total shareholder return. This...

Albertsons Companies reported past third-quarter 2025 results showing sales rising to US$19,123.7 million while net income and earnings per share from continuing operations declined year on year. Alongside narrowing its fiscal 2025 identical sales outlook due to Medicare drug price reforms, Albertsons affirmed a US$0.15 quarterly dividend and advanced its growing retail media platform. Next, we’ll examine how the narrowed identical sales guidance tied to Medicare drug pricing reshapes...

In the third quarter of 2025, Artisan Partners highlighted Polaris Inc. as a top contributor, crediting its inventory normalization, tariff mitigation through shifting sourcing, and focus on core powersports operations amid weak retail conditions. An interesting aspect of this recognition is how Polaris continued to return capital to shareholders via dividends and buybacks while contending with tariff-related uncertainty and soft demand. We’ll now examine how Polaris’s tariff-mitigation...

Tyler Technologies and Michigan’s Midland County Central Dispatch Authority have completed deployment of Tyler’s cloud-hosted Enterprise Computer Aided Dispatch, Enterprise Mobile, and Mobility solutions, replacing the county’s legacy CAD system after its prior vendor ended support. This rollout highlights Tyler’s role in mission-critical public safety infrastructure, supporting always-on dispatch continuity and information access for multiple law enforcement, fire, and EMS agencies handling...

Buckle has recently attracted renewed social media attention on platforms such as TikTok, as its mall-core denim and durable casual basics resonate with loyal customers and new denim enthusiasts alike. This resurgence highlights how Buckle’s focus on wearability and steady dividend payments is reinforcing its appeal among income-focused investors seeking consistency. We’ll now examine how this social media-driven brand resurgence may influence Buckle’s investment narrative built around...

The Timken Company recently reshaped its leadership, appointing John Szarka as chief technology officer to drive technology, AI and automation, while also promoting Sudesh Kumar and Diego Macario to lead the Americas and Europe regions respectively. This reorganization elevates technology and regional leadership as core levers for organic growth, sharper market focus and closer alignment with local customers. Next, we’ll explore how Timken’s new chief technology officer role could influence...

In recent days, Cloudflare has drawn heightened investor attention as it continues to outpace revenue and earnings forecasts while broadening its AI-optimized infrastructure and security offerings. This mix of consistent estimate beats and rapid platform expansion, even as analysts reassess their views, is sharpening market focus on how Cloudflare balances innovation with execution risk. Now, we’ll examine how Cloudflare’s push into AI-optimized infrastructure and enhanced security could...

In recent days, Globe Life Inc has come under pressure after a viral short-seller report and social media accusations about its sales culture and policy value hurt investor and customer confidence. This episode highlights how quickly reputation risk and online narratives can influence sentiment around a traditional life and health insurer like Globe Life. Next, we’ll examine how the short-seller-driven reputational shock may alter Globe Life’s previously steady investment narrative and risk...

Recent trading in Twist Bioscience (TWST) has drawn attention after the share price closed at US$36.87, with returns over the past month and the past 3 months both in positive territory. See our latest analysis for Twist Bioscience. That sharp 7 day share price return of 16.24% and 30 day share price return of 14.43% sit against a 1 year total shareholder return decline of 18.28%. The 3 year total shareholder return of 37.99% points to momentum that has emerged over a longer stretch, even as...

Why Skyward Specialty Insurance Group is on investors’ radar Skyward Specialty Insurance Group (SKWD) has recently drawn attention after a stretch of mixed share performance, with a 6% one day decline contrasting with modest gains over the past month. For investors tracking shorter term swings alongside business fundamentals, the stock’s recent pullback sits against annual revenue of US$1,335.4m and net income of US$141.2m, along with annual growth rates in both metrics near 19%. See our...

In late 2025, FanDuel and CME Group launched the FanDuel Predicts app across several U.S. states, offering event contracts on financial benchmarks, economic indicators, cultural events, and sports via a KYC-verified mobile platform with prices between $0.01 and $0.99 per contract. The rollout effectively brings prediction-market style trading on indices, commodities, cryptocurrencies, and macro data to a nationwide retail audience, expanding CME’s reach well beyond traditional institutional...

In recent days, JPMorgan analyst Reginald Smith reaffirmed his Overweight rating on LendingClub, basing his view on a constructive 2026 outlook for the broader financial sector and a more supportive interest rate backdrop for fintech lenders. This renewed analyst confidence highlights how expectations for a friendlier rate environment could influence how investors view LendingClub’s digital lending and banking platform. With JPMorgan’s sector outlook and supportive rate expectations in...

In recent days, Frontline plc has faced softer crude-tanker market conditions, as very large crude carrier spot freight benchmarks retreated from earlier elevated levels while OPEC+ decided in late 2025 to keep oil output policy unchanged through March 2026. These shifts in spot rates and export expectations are important because they directly influence Frontline’s near-term earnings power and the cash available for future dividends. We’ll now examine how weaker VLCC spot freight rates could...

The newly announced partnership between CDW (CDW) and Templar Shield on the ServiceNow AI Platform puts risk, security, and AI governance at the center of the story for investors watching CDW’s next phase. See our latest analysis for CDW. Despite the new ServiceNow partnership and recent management hires in its services arm, CDW’s share price return has been weak over the past year, with a 30 day share price return of an 8.14% decline, a 90 day share price return of a 14.39% decline, and a 1...

RLJ Lodging Trust (RLJ) is back in focus after two contrasting analyst calls, with Barclays taking a cautious view on leverage and hotel mix, while Raymond James issued an upgrade following strong quarterly results and a sector rally. See our latest analysis for RLJ Lodging Trust. At a share price of US$7.70, RLJ has posted an 11.11% 3 month share price return. However, its 1 year total shareholder return of 14.06% decline and 5 year total shareholder return of 36.29% decline suggest that...

Genius Sports recently held its second Investor Day, outlining a three-year outlook for revenue, adjusted EBITDA, and free cash flow that was above prior analyst expectations, while Arizona legal questions over prediction markets remained in the background. This stronger medium-term outlook, supported by analyst optimism around the company’s advertising potential, suggests investors are focusing more on Genius Sports’ core business model than on localized legal issues. We’ll now examine how...